Skip to main content
Premium Trial:

Request an Annual Quote

TGen Begins $1.3M ALS Gene Screening With Funds From MDA

NEW YORK, March 20 (GenomeWeb News) - Translational Genomics has begun collecting 1,000 patient samples to undergo screening for variants causing ALS, or Lou Gehrig's Disease, the company said today.

 

The project is being funded with a donation of $650,000 from Augie's Quest, administered by the Muscular Dystrophy Association, and with a matching investment of $650,000 from TGen, said project director Dietrich Stephen.

 

Stephen said that the screening will be done on an Affymetrix 500K platform.

 

The samples are being collected primarily from the University of Pittsburgh, California Pacific Medical Center, Methodist Neorological Institute, and the Western ALS Group.

 

Stephen said the project will be completed by the end of 2006.

The Scan

Octopus Brain Complexity Linked to MicroRNA Expansions

Investigators saw microRNA gene expansions coinciding with complex brains when they analyzed certain cephalopod transcriptomes, as they report in Science Advances.

Study Tracks Outcomes in Children Born to Zika Virus-Infected Mothers

By following pregnancy outcomes for women with RT-PCR-confirmed Zika virus infections, researchers saw in Lancet Regional Health congenital abnormalities in roughly one-third of live-born children.

Team Presents Benchmark Study of RNA Classification Tools

With more than 135 transcriptomic datasets, researchers tested two dozen coding and non-coding RNA classification tools, establishing a set of potentially misclassified transcripts, as they report in Nucleic Acids Research.

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.